Biotech

All Articles

Galapagos pauses CAR-T tissue treatment litigation over Parkinsonism case

.Galapagos has stopped briefly registration in a trial of a BCMA-directed CAR-T cell therapy, pumpin...

James Wilson leaving behind Penn to launch pair of brand new biotechs

.After more than 30 years, genetics treatment innovator James Wilson M.D., Ph.D., is leaving behind ...

3 biotechs make an effort to beat the summer heat by shedding personnel

.As biotechs try to turn a fresh web page in August, a minimum of three companies have lost staff in...

venBio lifts $528M for fifth life sciences VC fund

.Professional financial backing agency venBio has actually raised one more half a billion bucks to a...

Otsuka pays for $800M for Jnana as well as its clinical-stage PKU medicine

.Otsuka Pharmaceutical has gotten Boston-based Jnana Rehabs for $800 thousand so the Eastern biotech...

FibroGen lays off 75% of US staff as possession fails 2 more tests

.FibroGen is significantly reorganizing its organization, giving up 75% of its own united state team...

Tracon wane weeks after injectable PD-L1 inhibitor fall short

.Tracon Pharmaceuticals has made a decision to wane procedures weeks after an injectable invulnerabl...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M deal

.Ideaya Biosciences is actually betting $400 thousand in biobucks that a bispecific antibody-drug co...

Takeda takes $140M loss on neglected epilepsy medicine, boasts FDA run

.Our company already understand that Takeda is expecting to locate a pathway to the FDA for epilepsy...

VBI Vaccinations files for personal bankruptcy, looks for resource purchase

.Immunology biotech VBI Injections is drifting alarmingly near to the moment of truth, with planning...